Schedule 13G ownership disclosure

NEXUS BIOPHARMA INC

Security class unavailable · CUSIP: 65341U104

Event date: 2016-06-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,333,647
Percent of class
13.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001078782-16-003009
Form type
SC 13G
Filer
Albert Einstein College of Medicine, Inc.
CIK
CIK 1677398
Filed
Jun 20, 2016
Reporting period
Jun 09, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub